KEMET Reports Preliminary Fourth Quarter And Fiscal Year 2015 Results

May 5, 2015 8:11 AM EDT

GREENVILLE, S.C., May 5, 2015 /PRNewswire/ -- KEMET Corporation (the "Company") (NYSE: KEM), a leading global supplier of electronic components, today reported preliminary results for the fourth quarter and fiscal year ended March 31, 2015.

Net sales of $193.7 million for the quarter ended March 31, 2015 decreased 3.8% from net sales of $201.3 million for the prior quarter ended December 31, 2014, and decreased 10.2% compared to net sales of $215.8 million for the quarter ended March 31, 2014.  For the fiscal year ended March 31, 2015 net sales were $823.2 million compared to $833.7 million for the fiscal year ended March 31, 2014.

The U.S. GAAP net loss for the quarter ended March 31, 2015 was $19.8 million, or $0.44 loss per basic and diluted share, compared to a net loss for the quarter ended March 31, 2014 of $14.4 million or $0.32 loss per basic and diluted share.  For the fiscal year ended March 31, 2015, the net loss was $14.1 million, or $0.31 loss per diluted share compared to a net loss of $68.5 million, or $1.52 loss per diluted share for the fiscal year ended March 31, 2014.

The non-U.S. GAAP Adjusted net loss for the quarter ended March 31, 2015 was $1.6 million or $0.04 loss per basic and diluted share, compared to a non-U.S. GAAP Adjusted net income of $1.7 million or $0.03 per diluted share for the quarter ended March 31, 2014.  For the fiscal year ended March 31, 2015, the non-U.S. GAAP net income was $7.0 million, or $0.13 per diluted share compared to a net loss of $17.5 million, or $0.39 loss per basic and diluted share for the fiscal year ended March 31, 2014.

"We entered this fiscal year focused on improving Adjusted operating income and cash flow and we are pleased that our Adjusted operating income improved over $30.5 million compared to our prior fiscal year even with some currency headwinds in the last two quarters," stated Per Loof, KEMET's Chief Executive Officer.  "As we adjust to the reality of a strong U.S. dollar we believe we have positioned our cost structure to allow us to continue a trend of improving our Adjusted operating income for our next fiscal year as well," continued Loof.

The net income (loss) for the quarters ended March 31, 2015 and 2014 include various items affecting comparability as denoted in the U.S. GAAP to Non-U.S. GAAP reconciliation table included hereafter.

About KEMET

The Company's common stock is listed on the NYSE under the ticker symbol "KEM" (NYSE: KEM).  At the Investor Relations section of our web site at http://www.kemet.com/IR, users may subscribe to KEMET news releases and find additional information about our Company.  KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world's most complete line of surface mount and through-hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.

QUIET PERIOD

Beginning July 1, 2015, we will observe a quiet period during which the information provided in this news release and annual report on Form 10-K will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.

Factors that may cause the actual outcomes and results to differ materially from those expressed in, or implied by,  these forward-looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) continued net losses could impact our ability to realize current operating plans and could materially adversely affect our liquidity and our ability to continue to operate; (iii) adverse economic conditions could cause the write down of long-lived assets or goodwill; (iv) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased materials; (v) changes in the competitive environment; (vi) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vii) economic, political, or regulatory changes in the countries in which we operate; (viii) difficulties, delays or unexpected costs in completing the restructuring plans; (ix) equity method investment in NEC TOKIN exposes us to a variety of risks; (x) possible acquisition of NEC TOKIN may not achieve all of the anticipated results; (xi) acquisitions and other strategic transactions expose us to a variety of risks; (xii) our business could be negatively impacted by increased regulatory scrutiny and litigation (xiii) inability to attract, train and retain effective employees and management; (xiv) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xv) exposure to claims alleging product defects; (xvi) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xvii) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xviii) volatility of financial and credit markets affecting our access to capital; (xix) the need to reduce the total costs of our products to remain competitive; (xx) potential limitation on the use of net operating losses to offset possible future taxable income; (xxi) restrictions in our debt agreements that limit our flexibility in operating our business; (xxii) failure of our information technology systems to function properly or our failure to control unauthorized access to our systems may cause business disruptions; and (xxiii) additional exercise of the warrant by K Equity which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions.

 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations

(Amounts in thousands, except per share data)

(Unaudited)

Quarters Ended March 31,

Fiscal Year Ended

2015

2014

2015

2014

Net sales

$

193,708

$

215,821

$

823,192

$

833,666

Operating costs and expenses:

Cost of sales

157,379

182,203

663,683

712,925

Selling, general and administrative expenses

24,870

25,030

98,533

95,856

Research and development

6,572

6,762

25,802

24,466

Restructuring charges

3,437

5,954

13,017

14,122

Write down of long-lived assets

1,118

4,476

Net (gain) loss on sales and disposals of assets

538

(39)

(221)

32

Total operating costs and expenses

192,796

221,028

800,814

851,877

Operating income (loss)

912

(5,207)

22,378

(18,211)

Other (income) expense:

Interest income

(4)

(13)

(15)

(195)

Interest expense

10,020

10,671

40,701

40,962

Other income (expense), net

8,647

(2,632)

(6,182)

(2,681)

Income (loss) from continuing operations before income taxes and equity loss from NEC TOKIN

(17,751)

(13,233)

(12,126)

(56,297)

Income tax expense (benefit)

3

(2,811)

5,227

1,482

Income (loss) from continuing operations before equity loss from NEC TOKIN

(17,754)

(10,422)

(17,353)

(57,779)

Equity income (loss) from NEC TOKIN

(2,093)

(4,128)

(2,169)

(7,090)

Income (loss) from continuing operations

(19,847)

(14,550)

(19,522)

(64,869)

Income (loss) from discontinued operations

103

5,379

(3,634)

Net income (loss)

$

(19,847)

$

(14,447)

$

(14,143)

$

(68,503)

Net loss per basic and diluted share:

Income (loss) from continuing operations

$

(0.44)

$

(0.32)

$

(0.43)

$

(1.44)

Income (loss) from discontinued operations

$

$

$

0.12

$

(0.08)

Net income (loss)

$

(0.44)

$

(0.32)

$

(0.31)

$

(1.52)

Weighted-average shares outstanding:

Basic and diluted

45,443

45,174

45,381

45,102

 

 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(Amounts in thousands, except per share data)

(Unaudited)

March 31, 2015

March 31, 2014

ASSETS

Current assets:

Cash and cash equivalents

$

56,362

$

57,929

Accounts receivable, net

90,857

98,947

Inventories, net

171,843

187,974

Prepaid expenses and other

41,650

36,871

Deferred income taxes

11,012

6,695

Current assets of discontinued operations

12,160

Total current assets

371,724

400,576

Property and equipment

249,641

292,648

Goodwill

35,584

35,584

Intangible assets, net

33,282

37,184

Investment in NEC TOKIN

45,016

46,419

Restricted cash

1,775

13,512

Deferred income taxes

8,053

6,778

Other assets

11,056

10,130

Noncurrent assets of discontinued operations

836

Total assets

$

756,131

$

843,667

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Current portion of long-term debt

$

462

$

7,297

Accounts payable

69,785

74,818

Accrued expenses

60,456

76,468

Income taxes payable and deferred income taxes

337

980

Current liabilities of discontinued operations

7,269

Total current liabilities

131,040

166,832

Long-term debt, less current portion

390,909

391,292

Other non-current obligations

57,131

55,864

Deferred income taxes

9,427

5,203

Noncurrent liabilities of discontinued operations

2,592

Commitments and contingencies

Stockholders' equity:

Preferred stock, par value $0.01, authorized 10,000 shares, none issued

Common stock, par value $0.01, authorized 175,000 shares, issued 46,508 shares at March 31, 2015 and 2014

465

465

Additional paid-in capital

461,192

465,027

Retained deficit

(245,881)

(231,738)

Accumulated other comprehensive income

(25,855)

18,184

Treasury stock, at cost (1,057 and 1,301 shares at March 31, 2015 and 2014, respectively)

(22,297)

(30,054)

Total stockholders' equity

167,624

221,884

Total liabilities and stockholders' equity

$

756,131

$

843,667

 

 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Amounts in thousands)

(Unaudited)

Fiscal Years Ended March 31,

2015

2014

Net income (loss)

$

(14,143)

$

(68,503)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Gain on sale of discontinued operations

(5,644)

Net cash provided by (used in) operating activities of discontinued operations

(679)

336

Depreciation and amortization

40,768

49,527

Amortization of debt discount and debt issuance costs

2,032

3,596

Gain on early extinguishment of debt

(1,003)

Equity loss from NEC TOKIN

2,169

7,090

Change in value of NEC TOKIN options

(2,100)

(3,111)

Net (gain) loss on sales and disposals of assets

(221)

32

Stock-based compensation expense

4,512

2,909

Pension and other post-retirement benefits

(13,283)

(78)

Deferred income tax expense (benefit)

(1,257)

(6,369)

Write down of long-lived assets

4,476

Write down of receivables

52

1,484

Other, net

(7)

(521)

Changes in assets and liabilities:

Accounts receivable

8,220

(4,618)

Inventories

8,559

14,891

Prepaid expenses and other current assets

(8,550)

3,748

Accounts payable

(2,879)

(2,070)

Accrued income taxes

4,155

172

Other operating liabilities

3,701

(9,737)

Net cash provided by (used in) operating activities

24,402

(6,746)

Investing activities:

Capital expenditures

(22,232)

(32,147)

Change in restricted cash

11,509

4,047

Proceeds from sale of discontinued operations

9,564

Proceeds from sale of assets

4,788

2,847

Net cash provided by (used in) investing activities

3,629

(25,253)

Financing activities:

Proceeds from revolving line of credit

42,340

21,000

Payment of revolving line of credit

(27,342)

(2,551)

Deferred acquisition payments

(19,527)

(21,977)

Payments of long-term debt

(21,733)

(3,599)

Proceeds from exercise of stock options

24

250

Purchase of treasury stock

(630)

Net cash provided by (used in) financing activities

(26,868)

(6,877)

Net increase (decrease) in cash and cash equivalents

1,163

(38,876)

Effect of foreign currency fluctuations on cash

(2,730)

827

Cash and cash equivalents at beginning of fiscal period

57,929

95,978

Cash and cash equivalents at end of fiscal period

$

56,362

$

57,929

Non-U.S. GAAP Financial Measures

In this news release, the Company makes reference to certain Non-U.S. GAAP financial measures, including "Adjusted gross margin", "Adjusted operating income", "Adjusted net income (loss)", "Adjusted net income (loss) per share" and "Adjusted EBITDA".  Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management.

Adjusted Gross Margin

Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the quantitative reconciliation provided below.  Management uses Adjusted gross margin to facilitate our analysis and understanding of our business operations and believes that Adjusted gross margin is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company.  Adjusted gross margin should not be considered as an alternative to gross margin or any other performance measure derived in accordance with U.S. GAAP.

The following table provides a reconciliation from U.S. GAAP Gross margin to Non-U.S. GAAP Adjusted gross margin (amounts in thousands):

Quarters Ended

Fiscal Years Ended

March 31, 2015

December 31, 2014

March 31, 2014

March 31, 2015

March 31, 2014

(Unaudited)

Net sales

$

193,708

$

201,310

$

215,821

$

823,192

$

833,666

Gross Margin

36,329

44,468

33,618

159,509

120,741

Non-U.S. GAAP-adjustments:

Inventory Revaluation

(927)

(927)

Plant shut-down costs

2,668

889

2,668

Plant start-up costs

651

1,144

669

4,556

3,336

Stock-based compensation expense

465

424

186

1,577

1,008

Inventory write downs

3,886

Infrastructure tax

1,079

1,079

Adjusted gross margin

$

36,518

$

45,109

$

38,220

$

166,531

$

132,718

18.9

%

22.4

%

17.7

%

20.2

%

15.9

%

Adjusted Operating Income

Adjusted operating income represents operating income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided below. We use Adjusted operating income to facilitate our analysis and understanding of our business operations and believe that Adjusted operating income is useful to investors because it provides a supplemental way to understand our underlying operating performance. Adjusted operating income should not be considered as an alternative to operating income or any other performance measure derived in accordance with U.S. GAAP.

Adjusted operating income is calculated as follows (amounts in thousands):

Quarters Ended

Fiscal Year Ended

March 31, 2015

December 31, 2014 (1)

March 31, 2014

March 31, 2015

March 31, 2014

(Unaudited)

Operating income (loss)

$

912

$

9,302

$

(5,207)

22,378

(18,211)

Adjustments:

Restructuring charges

3,437

6,063

5,954

13,017

14,122

Plant shut-down costs

2,668

889

2,668

Write down of long-lived assets

1,118

4,476

ERP integration costs

1,273

671

837

3,248

3,880

Plant start-up costs

651

1,144

669

4,556

3,336

NEC TOKIN investment related expenses

226

485

618

1,778

2,299

Stock-based compensation expense

1,328

1,232

579

4,512

2,909

Inventory Revaluation

(927)

(927)

Inventory write downs

3,886

Infrastructure tax

1,079

1,079

Net (gain) loss on sales and disposals of assets

538

(574)

(39)

(221)

32

Legal expenses related to antitrust class actions

435

409

844

Adjusted operating income (loss)

$

7,873

$

17,805

$

8,276

51,001

20,476

(1) We have revised the quarter ended December 31, 2014 Non-GAAP presentation to conform with the quarter ended March 31, 2015.

Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share

"Adjusted net income (loss)" and "Adjusted net income (loss) per share" represent net income (loss) and net income (loss) per share excluding adjustments which are outlined in the quantitative reconciliation provided below.  Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company.  Management uses these Non-U.S. GAAP financial measures to evaluate operating performance.  Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP net income (loss) to Non-U.S. GAAP adjusted net income (loss):

U.S. GAAP to Non- U.S. GAAP Reconciliation

Quarters Ended

Fiscal Year Ended

March 31, 2015

December 31, 2014 (1)

March 31, 2014

March 31, 2015

March 31, 2014

(Unaudited, Amounts in thousands, except per share data)

U.S. GAAP

Net sales

$

193,708

$

201,310

$

215,821

$

823,192

$

833,666

Net income (loss)

$

(19,847)

$

2,914

$

(14,447)

$

(14,143)

$

(68,503)

Net income (loss) - basic eps

$

(0.44)

$

0.06

$

(0.32)

$

(0.31)

$

(1.52)

Net income (loss) - diluted eps

$

(0.44)

$

0.06

$

(0.32)

$

(0.31)

$

(1.52)

Non-U.S. GAAP

Net income (loss)

(19,847)

2,914

(14,447)

(14,143)

(68,503)

Adjustments:

Restructuring charges

3,437

6,063

5,954

13,017

14,122

Equity (gain) loss from NEC TOKIN

2,093

(1,367)

4,127

2,169

7,090

Write down of long-lived assets

1,118

4,476

Inventory write downs

3,886

ERP integration costs

1,273

671

837

3,248

3,880

Amortization included in interest expense

244

322

780

1,814

3,596

Plant start-up costs

651

1,144

669

4,556

3,336

Stock-based compensation

1,328

1,232

579

4,512

2,909

Plant shut-down costs

2,668

889

2,668

NEC TOKIN investment related expenses

226

485

618

1,778

2,299

(Gain) loss on early extinguishment of debt

(1,003)

(1,003)

Professional fees related to financing activities

1,142

1,142

Long-term receivable write down

1,444

(Gain) loss on sales and disposals of assets

538

(574)

(39)

(221)

32

(Income) loss from discontinued operations

164

(103)

(5,379)

3,634

Inventory Revaluation

(927)

(927)

Income tax effect of non-GAAP adjustments (2)

20

37

100

84

(27)

Net foreign exchange (gain) loss

(2,168)

(1,257)

(449)

(4,249)

(304)

Infrastructure tax

1,079

1,079

Change in value of NEC TOKIN options

11,100

(2,500)

(1,777)

(2,100)

(3,111)

Legal expenses related to antitrust class actions

435

409

844

Adjusted net income (loss)

$

(1,597)

$

6,955

$

1,714

$

6,958

$

(17,494)

Adjusted net income (loss) per basic share

$

(0.04)

$

0.15

$

0.04

$

0.15

$

(0.39)

Adjusted net income (loss) per diluted share

$

(0.04)

$

0.13

$

0.03

$

0.13

$

(0.39)

Weighted average shares outstanding:

Basic

45,443

45,407

45,174

45,381

45,102

Diluted

45,443

52,228

52,523

52,588

45,102

(1) We have revised the quarter ended December 31, 2014 Non-GAAP presentation to conform with the quarter ended March 31, 2015.

(2) The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction.

Adjusted EBITDA

Adjusted EBITDA represents net income (loss) before net interest expense, income tax expense, and depreciation and amortization expense, adjusted to exclude certain item which are outlined in the quantitative reconciliation provided below.  We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business.  We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt.  We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other adjustments to arrive at Adjusted EBITDA are excluded in order to better reflect our continuing operations.

In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below.  Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments.  Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.

Our Adjusted EBITDA measure has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.  Some of these limitations are:

  • it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
  • it does not reflect changes in, or cash requirements for, our working capital needs;
  • it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;
  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements;
  • it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
  • it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;
  • it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and
  • other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations.  You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.

The following table provides a reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):

Fiscal Year 2015

Q1

Q2

Q3 (1)

Q4

Total

Net income (loss)

$

(3,540)

$

6,330

$

2,914

$

(19,847)

$

(14,143)

Adjustments:

Income tax expense

1,282

2,583

1,359

3

5,227

Interest expense, net

10,453

10,284

9,933

10,017

40,687

Depreciation and amortization

10,797

10,177

9,720

10,074

40,768

Restructuring charges

1,830

1,687

6,063

3,437

13,017

(Income) loss from discontinued operations

(6,943)

1,400

164

(5,379)

ERP integration costs

895

409

671

1,273

3,248

Plant start-up costs

1,647

1,114

1,144

651

4,556

Plant shut-down costs

889

889

NEC TOKIN investment related expenses

580

487

485

226

1,778

Stock-based compensation

994

958

1,232

1,328

4,512

(Gain) loss on sales and disposals of assets

365

(550)

(574)

538

(221)

Change in value of NEC TOKIN options

(4,100)

(6,600)

(2,500)

11,100

(2,100)

Inventory revaluation

2,676

(822)

(927)

(927)

Equity (gain) loss from NEC TOKIN

1,675

(232)

(1,367)

2,093

2,169

Net foreign exchange (gain) loss

527

(1,351)

(1,257)

(2,168)

(4,249)

(Gain) loss on early extinguishment of debt

(1,003)

(1,003)

Professional fees related to financing activities

1,142

1,142

Legal expenses related to antitrust class actions

409

435

844

Adjusted EBITDA

$

20,027

$

25,874

$

27,608

$

18,233

$

91,742

 (1) We have revised the quarter ended December 31, 2014 Non-GAAP presentation to conform with the quarter ended March 31, 2015.

Fiscal Year 2014

Q1

Q2

Q3

Q4

Total

Net income (loss)

$

(35,140)

$

(13,096)

$

(5,820)

$

(14,447)

$

(68,503)

Adjustments:

Income tax expense

1,816

1,444

1,033

(2,811)

1,482

Interest expense, net

9,870

9,897

10,342

10,658

40,767

Depreciation and amortization

13,639

11,951

11,762

12,175

49,527

(Income) loss from discontinued operations

1,510

1,151

1,076

(103)

3,634

Restructuring charges

4,610

1,364

2,194

5,954

14,122

Write down of long-lived assets

3,358

1,118

4,476

ERP integration costs

978

1,071

994

837

3,880

Plant start-up costs

1,132

1,050

485

669

3,336

Plant shut-down costs

2,668

2,668

NEC TOKIN investment related expenses

1,308

124

249

618

2,299

Stock-based compensation

969

659

702

579

2,909

(Gain) loss on sales and disposals of assets

42

29

(39)

32

Change in value of NEC TOKIN options

382

(1,716)

(1,777)

(3,111)

Inventory write downs

3,886

3,886

Long-term receivable write down

1,444

1,444

Equity (gain) loss from NEC TOKIN

3,377

1,243

(1,657)

4,127

7,090

Net foreign exchange (gain) loss

(577)

515

207

(449)

(304)

Infrastructure Tax

1,079

1,079

Adjusted EBITDA

$

8,822

$

17,797

$

23,238

$

20,856

$

70,713

 

Contact:

William M. Lowe, Jr.

Richard J. Vatinelle

Executive Vice President and

Vice President and

Chief Financial Officer

Treasurer

[email protected]

[email protected]

864-963-6484

954-766-2800

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kemet-reports-preliminary-fourth-quarter-and-fiscal-year-2015-results-300077518.html

SOURCE KEMET Corporation



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Earnings, Definitive Agreement